Skip to main content
. 2021 Jan 18;41(8):1954–1963. doi: 10.1177/0271678X20982389

Table 1.

Patient characteristics.

PD Sex Age Years since surgery L-DOPA equivalents UPDRS p. I-IV UPDRS p. III
HYR
DBS-ON DBS-ON DBS-OFF DBS-OFF
1 M 55 7 531 n.a n.a n.a 2
2 M 66 1.7 469 48 20 47 2
3 M 53 3.4 967 15 7 34 2
4 M 59 2.7 391 34 25 66 2
5 M 72 5.5 815 44 11 37 3
6 M 67 0.5 430 9 0 26 2
7 F 56 0.8 532 21 4 15 1
8 F 63 2.5 479 22 7 41 2
9 F 50 1.2 500 36 7 55 2
10 F 65 1.8 305 36 7 29 2
11 M 50 2.6 385 36 7 28 2
12 M 62 2.6 1896 73 27 41 2
13 M 56 0.7 835 22 0 23 2
Mean ± SD 60 ± 7 2.5 ± 1.8 656 ± 405 33 ± 16 10 ± 9 37 ± 14 2.0 ± 0.4

Male (M), Female (F), levodopa (L-DOPA) or equipotent to L-DOPA, Deep Brain Stimulation (DBS), Unified Parkinson Disease Rating Scale (UPDRS) and motor scores part III (UPDRS-motor), Hoehn and Yahr Rating scale (HYR).